NO170014C - Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre - Google Patents
Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyreInfo
- Publication number
- NO170014C NO170014C NO860273A NO860273A NO170014C NO 170014 C NO170014 C NO 170014C NO 860273 A NO860273 A NO 860273A NO 860273 A NO860273 A NO 860273A NO 170014 C NO170014 C NO 170014C
- Authority
- NO
- Norway
- Prior art keywords
- amino
- sulphoxy
- oxoethylidene
- azetidinyl
- thiazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/18—Salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/695,775 US4638061A (en) | 1985-01-28 | 1985-01-28 | [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO860273L NO860273L (no) | 1986-07-29 |
| NO170014B NO170014B (no) | 1992-05-25 |
| NO170014C true NO170014C (no) | 1992-09-02 |
Family
ID=24794413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860273A NO170014C (no) | 1985-01-28 | 1986-01-27 | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US4638061A (xx) |
| JP (2) | JPH0780840B2 (xx) |
| KR (1) | KR900000675B1 (xx) |
| CN (1) | CN1014894B (xx) |
| AR (1) | AR242024A1 (xx) |
| AT (1) | AT389511B (xx) |
| AU (1) | AU588017B2 (xx) |
| BE (1) | BE904121A (xx) |
| CA (2) | CA1283924C (xx) |
| CH (3) | CH670824A5 (xx) |
| CS (1) | CS253740B2 (xx) |
| DD (3) | DD241600A5 (xx) |
| DE (1) | DE3602347A1 (xx) |
| DK (1) | DK39486A (xx) |
| EG (1) | EG17682A (xx) |
| ES (3) | ES8706112A1 (xx) |
| FI (1) | FI85022C (xx) |
| FR (1) | FR2576596B1 (xx) |
| GB (2) | GB2170201B (xx) |
| GR (1) | GR860239B (xx) |
| HU (1) | HU196367B (xx) |
| IE (2) | IE59629B1 (xx) |
| IL (1) | IL77661A (xx) |
| IT (1) | IT1190604B (xx) |
| LU (1) | LU86262A1 (xx) |
| NL (1) | NL8600136A (xx) |
| NO (1) | NO170014C (xx) |
| NZ (1) | NZ214836A (xx) |
| PH (3) | PH22425A (xx) |
| PL (3) | PL262318A1 (xx) |
| PT (1) | PT81914B (xx) |
| RO (1) | RO93483B (xx) |
| SE (3) | SE467824B (xx) |
| YU (2) | YU45760B (xx) |
| ZA (1) | ZA86302B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751220A (en) * | 1986-12-19 | 1988-06-14 | E. R. Squibb & Sons, Inc. | Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid |
| US5143913A (en) * | 1988-04-04 | 1992-09-01 | E. R. Squibb & Sons, Inc. | [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate |
| EP0336667A3 (en) * | 1988-04-04 | 1991-04-10 | E.R. Squibb & Sons, Inc. | [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate |
| US4973747A (en) * | 1989-08-15 | 1990-11-27 | E. R. Squibb & Sons, Inc. | Process for preparing 3-hydroxy 2-keto acids |
| DK2484680T3 (da) * | 2005-12-07 | 2013-09-08 | Basilea Pharmaceutica Ag | Nyttige kombinationer af monolactam-antibiotika med beta-lactamase-inhibitorer |
| WO2017180794A1 (en) | 2016-04-13 | 2017-10-19 | Skyline Antiinfectives, Inc. | Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4337197A (en) * | 1980-10-31 | 1982-06-29 | E. R. Squibb & Sons, Inc. | O-sulfated β-lactam hydroxamic acids and intermediates |
| JPS58113174A (ja) * | 1981-12-26 | 1983-07-05 | Toyama Chem Co Ltd | 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤 |
| JPS58194856A (ja) * | 1982-05-10 | 1983-11-12 | Yamanouchi Pharmaceut Co Ltd | 新規２−アゼチジノン誘導体 |
| JPS58206589A (ja) * | 1982-05-26 | 1983-12-01 | Yamanouchi Pharmaceut Co Ltd | ２−アゼチジノン誘導体 |
| US4565654A (en) * | 1983-03-28 | 1986-01-21 | University Of Notre Dame Du Lac | N-Acyloxy monocyclic β-lactams |
-
1985
- 1985-01-28 US US06/695,775 patent/US4638061A/en not_active Expired - Fee Related
-
1986
- 1986-01-15 NZ NZ214836A patent/NZ214836A/xx unknown
- 1986-01-15 GB GB08600825A patent/GB2170201B/en not_active Expired
- 1986-01-15 ZA ZA86302A patent/ZA86302B/xx unknown
- 1986-01-15 CA CA000499611A patent/CA1283924C/en not_active Expired - Lifetime
- 1986-01-16 PH PH33290A patent/PH22425A/en unknown
- 1986-01-16 YU YU5886A patent/YU45760B/sh unknown
- 1986-01-17 AU AU52460/86A patent/AU588017B2/en not_active Ceased
- 1986-01-17 FR FR868600631A patent/FR2576596B1/fr not_active Expired
- 1986-01-20 FI FI860247A patent/FI85022C/fi not_active IP Right Cessation
- 1986-01-21 IL IL77661A patent/IL77661A/xx not_active IP Right Cessation
- 1986-01-22 LU LU86262A patent/LU86262A1/fr unknown
- 1986-01-22 NL NL8600136A patent/NL8600136A/xx not_active Application Discontinuation
- 1986-01-24 IE IE20586A patent/IE59629B1/en not_active IP Right Cessation
- 1986-01-24 IE IE930750A patent/IE930750L/xx unknown
- 1986-01-26 EG EG35/86A patent/EG17682A/xx active
- 1986-01-27 DE DE19863602347 patent/DE3602347A1/de not_active Ceased
- 1986-01-27 ES ES551252A patent/ES8706112A1/es not_active Expired
- 1986-01-27 NO NO860273A patent/NO170014C/no unknown
- 1986-01-27 PT PT81914A patent/PT81914B/pt not_active IP Right Cessation
- 1986-01-27 CH CH2357/88A patent/CH670824A5/fr not_active IP Right Cessation
- 1986-01-27 CH CH2358/88A patent/CH670825A5/fr not_active IP Right Cessation
- 1986-01-27 RO RO122011A patent/RO93483B/ro unknown
- 1986-01-27 HU HU86375A patent/HU196367B/hu not_active IP Right Cessation
- 1986-01-27 DK DK39486A patent/DK39486A/da not_active Application Discontinuation
- 1986-01-27 KR KR1019860000501A patent/KR900000675B1/ko not_active IP Right Cessation
- 1986-01-27 SE SE8600355A patent/SE467824B/sv not_active IP Right Cessation
- 1986-01-27 CH CH305/86A patent/CH667872A5/fr not_active IP Right Cessation
- 1986-01-28 DD DD86286545A patent/DD241600A5/de not_active IP Right Cessation
- 1986-01-28 GR GR860239A patent/GR860239B/el unknown
- 1986-01-28 CS CS86625A patent/CS253740B2/cs unknown
- 1986-01-28 AR AR86302968A patent/AR242024A1/es active
- 1986-01-28 JP JP61017708A patent/JPH0780840B2/ja not_active Expired - Lifetime
- 1986-01-28 BE BE0/216191A patent/BE904121A/fr not_active IP Right Cessation
- 1986-01-28 PL PL1986262318A patent/PL262318A1/xx unknown
- 1986-01-28 PL PL1986262317A patent/PL149156B1/pl unknown
- 1986-01-28 IT IT19206/86A patent/IT1190604B/it active
- 1986-01-28 PL PL25766886A patent/PL257668A1/xx unknown
- 1986-01-28 AT AT0020386A patent/AT389511B/de not_active IP Right Cessation
- 1986-01-28 CN CN86100736A patent/CN1014894B/zh not_active Expired
- 1986-01-28 DD DD86292942A patent/DD248592A5/de unknown
- 1986-01-28 DD DD86292943A patent/DD248584A5/de unknown
- 1986-09-09 ES ES557057A patent/ES8801917A1/es not_active Expired
- 1986-09-09 ES ES557056A patent/ES8800897A1/es not_active Expired
-
1987
- 1987-02-18 PH PH34871A patent/PH23084A/en unknown
- 1987-02-18 PH PH34872A patent/PH23093A/en unknown
- 1987-09-08 YU YU01670/87A patent/YU167087A/xx unknown
-
1988
- 1988-01-08 GB GB08800425A patent/GB2198133B/en not_active Expired
-
1989
- 1989-11-24 CA CA000615565A patent/CA1279322C/en not_active Expired - Lifetime
-
1990
- 1990-07-03 SE SE9002338A patent/SE468896B/sv not_active IP Right Cessation
- 1990-07-03 SE SE9002337A patent/SE502442C2/sv not_active IP Right Cessation
-
1995
- 1995-02-21 JP JP7032368A patent/JPH0853404A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO171853C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser | |
| NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
| NO171787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser | |
| NO163857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser. | |
| NO872946L (no) | Analogifremgangsmte for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser. | |
| NO165397C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO870049L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| FI871087A (fi) | Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi | |
| NO863373D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater. | |
| NO170014C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO873680L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| AU610175B2 (en) | Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis | |
| IL84521A0 (en) | Salts of(3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoethylidene)-amino)oxy)acetic acid,process for the preparation thereof and pharmaceutical compositions containing the same | |
| NO168530C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
| NO169071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner | |
| NO171726C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3((1,2,3-tiadiazol-4-yl)tiometyl)-8-okso-5-tia-1-azabicyklo(4.2.0)okt-2-en-2-karboksylsyrederivater | |
| NO882728L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4(5)-substituerte imidazol-derivater. | |
| NO912745L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser. | |
| NO172119C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazol-forbindelser | |
| NO162239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. |